Patents Assigned to Genaissance Pharmaceuticals
  • NTRK1 genetic markers associated with progression of Alzheimer's disease
    Publication number: 20060166219
    Abstract: Haplotypes in the NTRK1 gene associated with progression of Alzheimer's Disease are disclosed. Compositions and methods for detecting these NTRK1 haplotypes are disclosed.
    Type: Application
    Filed: November 22, 2004
    Publication date: July 27, 2006
    Applicant: Genaissance Pharmaceuticals
    Inventors: Jeroen Aerssens, Maria Athanasiou, Carlos Brain, Nadine Cohen, Bradley Dain, R. Denton, Richard Judson, Vural Ozdemir, Carol Reed
  • CHRNA9 genetic markers associated with progression of Alzheimer's disease
    Publication number: 20050255492
    Abstract: Haplotypes in the CHRNA9 gene associated with progression of Alzheimer's Disease are disclosed. Compositions and methods for detecting these CHRNA9 haplotypes are disclosed.
    Type: Application
    Filed: November 22, 2004
    Publication date: November 17, 2005
    Applicant: Genaissance Pharmaceuticals
    Inventors: Jeroen Aerssens, Maria Athanasiou, Carlos Brain, Nadine Cohen, Bradley Dain, R. Denton, Richard Judson, Vural Ozdemir, Carol Reed
  • APOA4 genetic markers associated with progression of Alzheimer's disease
    Publication number: 20050250122
    Abstract: Haplotypes in the APOA4 gene associated with progression of Alzheimer's Disease are disclosed. Compositions and methods for detecting these APOA4 haplotypes are disclosed.
    Type: Application
    Filed: November 22, 2004
    Publication date: November 10, 2005
    Applicant: Genaissance Pharmaceuticals
    Inventors: Jeroen Aerssens, Maria Athanasiou, Carlos Brain, Nadine Cohen, Bradley Dain, R. Denton, Richard Judson, Vural Ozdemir, Carol Reed
  • NTRK2 genetic markers associated with progression of Alzheimer's disease
    Publication number: 20050250121
    Abstract: Haplotypes in the NTRK2 gene associated with progression of Alzheimer's Disease are disclosed. Compositions and methods for detecting these NTRK2 haplotypes are disclosed.
    Type: Application
    Filed: November 22, 2004
    Publication date: November 10, 2005
    Applicant: Genaissance Pharmaceuticals
    Inventors: Jeroen Aerssens, Maria Athanasiou, Carlos Brain, Nadine Cohen, Bradley Dain, R. Denton, Richard Judson, Vural Ozdemir, Carol Reed
  • Genome anthologies for harvesting gene variants
    Patent number: 5972614
    Abstract: The present invention relates to the development of collections of a single gene locus from a collection of individuals or organisms, called genome anthologies. The invention describes several novel methods for producing collections of a gene or gene families from multiple individuals or organisms. One method is targeted in vivo cloning. Another method is locus specific primer extension and exonuclease degradation method.
    Type: Grant
    Filed: December 10, 1997
    Date of Patent: October 26, 1999
    Assignee: Genaissance Pharmaceuticals
    Inventors: Gualberto Ruano, Kevin L. Bentley, Frank H. Ruddle